← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 5, 2017Last known activity
Feb 15, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT06478602Lead sponsorPhase 3Feb 15, 2023
- NCT06478602Sponsor investigatorPhase 3Feb 15, 2023
- NCT03340103CollaboratorN/AOct 1, 2017
- NCT03175341Reponsible party - principal investigatorPhase 1/Phase 2Jun 5, 2017
- NCT03175341Study directorPhase 1/Phase 2Jun 5, 2017
- NCT03175341Lead sponsorPhase 1/Phase 2Jun 5, 2017
Details
- Last known activity
- Feb 15, 2023